Axonics, Inc. revenue for the last year amounted to 366.38 M USD, the most of which — 291.81 M USD — came from its highest performing source at the moment, Sacral Neuromodulation, the year earlier bringing 221.99 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Axonics, Inc. 343.88 M USD, and the year before that — 257.04 M USD.